Role of Intellectual Property Rights in Biotechnology Innovation

Häftad, Engelska, 2011

949 kr

Beställningsvara. Skickas inom 5-8 vardagar. Fri frakt för medlemmar vid köp för minst 249 kr.

Intellectual property rights (IPRs), particularly patents, occupy a prominent position in innovation systems, but to what extent they support or hinder innovation is widely disputed. Through the lens of biotechnology, this book delves deeply into the main issues at the crossroads of innovation and IPRs to evaluate claims of the positive and negative impacts of IPRs on innovation. An international group of scholars from a range of disciplines - economic geography, health law, business, philosophy, history, public health, management - examine how IPRs actually operate in innovation systems, not just from the perspective of theory but grounded in their global, regional, national, current and historical contexts. In so doing, the contributors seek to uncover and move beyond deeply held assumptions about the role of IPRs in innovation systems.Scholars and students interested in innovation, science and technology policy, intellectual property rights and technology transfer will find this volume of great interest. The findings will also be of value to decision makers in science and technology policy and managers of intellectual property in biotechnology and venture capital firms.

Produktinformation

Utgivningsdatum2011-04-29
Mått156 x 234 x undefined mm
FormatHäftad
SpråkEngelska
FörlagEdward Elgar Publishing Ltd
ISBN9781848447882

Tillhör följande kategorier

Immaterialrätt inom Juridik

Contents:IntroductionDavid CastlePART I: INTELLECTUAL PROPERTY RIGHTS IN INNOVATION SYSTEMS1. IntroductionDavid Castle1. Are Intellectual Property Rights Quanta of Innovation?J. Adam Holbrook2. Intellectual Property Rights and Innovation Systems: Issues for Governance in a Global ContextBjørn Asheim, Finn Valentin and Christian Zeller3. Intellectual Property Rights Policy for Gene-Related Inventions – Toward Optimum Balance Between Public and Private OwnershipKoichi SumikuraPART II: INTELLECTUAL PROPERTY MANAGEMENT IN BIOTECHNOLOGYIntroductionKaren L. Durell4. Fundamentals of Intellectual Property ManagementPatrick H. Sullivan5. Making a Return on R&D: A Business PerspectiveSharon Oriel6. Looking Beyond the Firm: Intellectual Asset Management and BiotechnologyKaren L. Durell and E. Richard GoldPART III: INTELLECTUAL PROPERTY RIGHTS IN RELATION TO OTHER MEASURES OF INNOVATIONIntroductionL. Martin Cloutier and David Castle7. Increasing Internal Value from Patents: The Role of Organizational ArrangementsMarc Ingham, Cecile Ayerbe, Emmanuel Métais and Liliana Mitkova8. Language System (LS) 3.0: An Agenda for a Model of Innovation ValuationClinton W. Francis9. Measurement of Innovation and Intellectual Property Management: Challenging ProcessesL. Martin Cloutier and Susanne SiroisPART IV: BEYOND PATENT LENGTHIntroductionAmy J. Glass and Fabricio X. Nunez10. Open Development: Is the ‘Open Source’ Analogy Relevant to Biotechnology?Alan G. Isaac and Walter G. Park11. On the Border: Biotechnology, the Scope of Intellectual Property and the Dissemination of Scientific BenefitsChristopher May12. On the Comparative Institutional Economics of Intellectual Property in BiotechnologyF. Scott KieffPART V: INNOVATION GOVERNANCEIntroductionTania Bubela13. Accessibility of Biological Data: A Role for the European Database Right?Jasper A. Bovenberg14. Biotechnology Patents, Public Trust and Patent Pools: The Need for Governance?Timothy Caulfield15. Agricultural Biotechnology and Trends in the Intellectual Property Rights Regime: Emerging Challenges for Developing CountriesSachin ChaturvediPART VI: NATIONAL, INTERNATIONAL AND HISTORICAL COMPARISONSIntroductionAbdallah S. Daar and David Castle16. The Role of Intellectual Property Rights in Biotechnology Innovation: National and International ComparisonsRichard Y. Boadi17. Intellectual Property, Information and Divergences in Economic Development – Institutional Patterns and Outcomes circa 1421–2000Ian Inkster18. Watch What You Export: The History of Medical Exceptions from PatentabilityTina PiperIndex